Skip to main content

Table 3 Summary of Piperacillin/Tazobactam appropriate usage

From: Prospective evaluating the appropriate use of piperacillin /tazobactam in cardiac center of a tertiary care hospital

Criteria

Appropriate n (%)

Inappropriate

Starting according to microbiology test

14 (4.7%)

 

Continued according to the microbiological test

66\130 (22%)

 

Discontinuation of therapy after negative culture

64/130 (21.3%)

 

De-Escalation to an alternative after culture data showed sensitivity to narrow spectrum antibiotic

22/54 (7.3%)

 

Discontinuation once the culture data showed Pip/Taz resistant organism

16 (5.3%)

 

Patients had appropriate Pip/Taz use

166 (55.3%)

134 (44.7%)